Skip to main content

Table 5 Clinical treatments and outcomes in nalidixic acid-susceptible Salmonella (NASS) and nalidixic acid-resistant Salmonella (NARS)-infected patients treated with fluoroquinolones onlya

From: Genetic Diversity of Salmonella enteric serovar Typhi and Paratyphi in Shenzhen, China from 2002 through 2007

Antimicrobial agents   NASS-infected patients (n = 6) NARS-infected patients (n = 17)
  Dosage Number Duration (d) Number Duration (d)
Ciprofloxacin 0.4 g IV q12h 5 7~13 8 7~21
  0.2 g IV q12h 1 5 2 10~15
Levofloxacin 0.3 g IV q12h - - 1 7
  0.2 g IV q12h - - 2 7~8
Gatifloxacin 0.2 g IV q12h - - 3 10~14
  0.4 g IV q24h - - 1 13
  1. aAll of these 23 patients treated with fluoroquinolones only were cured.